Fast Track Initiative

Fast Track Initiative is a venture capital firm in Tokyo that focuses on life sciences and healthcare services. Founded 2004 in Tokyo, Japan by Hiromichi Kimura, it invests in early stage ventures and seed. Its portfolio companies include Cytlimic, PuREC, Modalis Therapeutics, mediPhone, PENTAS,Mentalhealth Technologies, YUKASHIKADO, Braizon Therapeutics, Inc., Modulus Discovery, and RIN Institute. As of April 2020, Fast Track Initiative has made 23 investments. Their most recent investment was on August 9, 2019, when Cytlimic raised ¥1.3B. Fast Track Initiative has had one exit, which was CellSeed.

Fast Track Initiative is a venture capital firm in Tokyo that focuses on life sciences and healthcare services. Founded 2004 in Tokyo, JapanJapan by Hiromichi Kimura, it invests in early stage ventures and seed. Its portfolio companies include Cytlimic, PuREC, Modalis Therapeutics, mediPhone, PENTAS,Mentalhealth Technologies, YUKASHIKADO, Braizon Therapeutics, Inc., Modulus Discovery, and RIN Institute. As of April 2020, Fast Track Initiative has made 23 investments. Their most recent investment was on August 9, 2019, when Cytlimic raised ¥1.3B. Fast Track Initiative has had one exit, which was CellSeed.

Fast Track Initiative is a venture capital firm in Tokyo that focuses on life sciences and healthcare services. Founded 2004 in Tokyo, Japan by Hiromichi Kimura, it invests in early stage ventures and seed. Its portfolio companies include Cytlimic, PuRECPuREC, Modalis Therapeutics, mediPhone, PENTAS,Mentalhealth Technologies, YUKASHIKADO, Braizon Therapeutics, Inc., Modulus Discovery, and RIN Institute. As of April 2020, Fast Track Initiative has made 23 investments. Their most recent investment was on August 9, 2019, when Cytlimic raised ¥1.3B. Fast Track Initiative has had one exit, which was CellSeed.